Separation of anxiety and depressive disorders

BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7419.870-a (Published 09 October 2003) Cite this as: BMJ 2003;327:870

Authors' reply

  1. Peter Tyrer, head of department (p.tyrer@imperial.ac.uk),
  2. Edward Shorter, professor of the history of medicine
  1. 1Department of Psychological Medicine, Imperial College Faculty of Medicine, St Mary's Campus, London W2 1PD
  2. 2History of Medicine Programme, University of Toronto, Toronto, ON, Canada M5G 1VJ

    EDITOR—Our article merely points to an inefficiency in drug development that seems to be driven by commercial imperatives, and as the targets are phoney diagnoses no advance is made. If we merely promote new indications for old drugs and dump existing compounds when they lose their patents is it surprising that depression and anxiety remain such major causes of morbidity?

    Weeks is right to assert that …

    View Full Text

    Sign in

    Log in through your institution